Cheng Xiong Lin
Amministratore Delegato presso Hunan Huairen Great Health Industry Development Co., Ltd.
Posizioni attive di Cheng Xiong Lin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Hunan Huairen Great Health Industry Development Co., Ltd.
 Hunan Huairen Great Health Industry Development Co., Ltd. Drugstore ChainsRetail Trade Part of LBX Pharmacy Chain JSC, Hunan Huairen Great Health Industry Development Co., Ltd. sells Chinese medicine, Chinese medicinal materials, and antibiotic preparations. The company is based in Huaihua, China. The Chinese company was founded in 1996. The CEO is Cheng Xiong Lin. Hunan Huairen Great Health Industry Development Co. was acquired by LBX Pharmacy Chain JSC on April 20, 2022 for $257.04 million. | Amministratore Delegato | - | - |
| Presidente | - | - |
Storia della carriera di Cheng Xiong Lin
Statistiche
Distribuzione geografica
| Cina | 2 |
Posizioni
| Chief Executive Officer | 1 |
| Chairman | 1 |
Settori
| Retail Trade | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Hunan Huairen Great Health Industry Development Co., Ltd.
Hunan Huairen Great Health Industry Development Co., Ltd. Drugstore ChainsRetail Trade Part of LBX Pharmacy Chain JSC, Hunan Huairen Great Health Industry Development Co., Ltd. sells Chinese medicine, Chinese medicinal materials, and antibiotic preparations. The company is based in Huaihua, China. The Chinese company was founded in 1996. The CEO is Cheng Xiong Lin. Hunan Huairen Great Health Industry Development Co. was acquired by LBX Pharmacy Chain JSC on April 20, 2022 for $257.04 million. | Retail Trade |
- Borsa valori
- Insiders
- Cheng Xiong Lin
- Esperienza
